F

Forte Biosciences
D

FBRX

12.620
USD
-0.98
(-7.21%)
مغلق
حجم التداول
309
الربح لكل سهم
-5
العائد الربحي
-
P/E
-1
حجم السوق
83,082,281
أصول ذات صلة
AZN
AZN
-2.580
(-3.51%)
70.970 USD
BMY
BMY
-1.435
(-2.95%)
47.215 USD
GSK
GSK
-0.795
(-1.96%)
39.715 USD
LLY
LLY
-16.42
(-2.03%)
791.23 USD
MRK
MRK
-2.690
(-3.32%)
78.290 USD
NVO
NVO
-2.710
(-3.52%)
74.310 USD
NVS
NVS
-1.720
(-1.46%)
116.420 USD
PFE
PFE
-0.410
(-1.68%)
23.995 USD
SNY
SNY
-1.200
(-2.43%)
48.240 USD
V
VTRS
-0.23500
(-2.62%)
8.75000 USD
المزيد
الأخبار المقالات

العنوان: Forte Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indicationsas graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).